Munk Dialogue on the bivalent COVID-19 booster: do the benefits outweigh the risks?
发布时间 2022-10-21 13:50:18 来源
摘要
Health Canada, the FDA, and the CDC have approved COVID bivalent vaccines to anyone over the age of 12. This booster is different from previous COVID shots, targeting multiple strains of the novel coronavirus, including Omicron sub variants. And while the vaccine is being widely distributed, some epidemiologists are sounding the alarm. Dr. Paul Offit, Director of the Vaccine Education Center and attending physician in the Division of Infectious Diseases at Children’s Hospital of Philadelphia, is one of two members on the FDA committee who voted against advising all adults over the age of 12 to get the jab. He joins us to talk about why this booster might not be necessary, and whether its benefits really outweigh the risks.
The host of the Munk Debates is Rudyard Griffiths - @rudyardg.
Tweet your comments about this episode to @munkdebate or comment on our Facebook page https://www.facebook.com/munkdebates/
To sign up for a weekly email reminder for this podcast, send an email to podcast@munkdebates.com.
To support civil and substantive debate on the big questions of the day, consider becoming a Munk Member at https://munkdebates.com/membership
Members receive access to our 10+ year library of great debates in HD video, a free Munk Debates book, newsletter and ticketing privileges at our live events.
This podcast is a project of the Munk Debates, a Canadian charitable organization dedicated to fostering civil and substantive public dialogue - https://munkdebates.com/
Producer: Ricki Gurwitz
GPT-4正在为你翻译摘要中......
